Therefore, we planned our study to evaluate Lp(a) as a cardiovascular risk factor in ≤/>45 years of age patients presenting with first episode of acute coronary syndrome and angiographically normal persons as controls, so as to consider Lp(a) in age stratified strategies to effectively target our high-risk patients with coronary vascular disease. This evidence concerns the gene LPA and acute coronary syndrome.